![The New Era of Therapeutic Strategies for the Treatment of Retinitis Pigmentosa: From Pathomolecular Mechanisms to the Development of Cell-Based Therapies[v1] | Preprints.org The New Era of Therapeutic Strategies for the Treatment of Retinitis Pigmentosa: From Pathomolecular Mechanisms to the Development of Cell-Based Therapies[v1] | Preprints.org](https://www.preprints.org/img/dyn_abstract_figures/2023/09/66e54ff91169e9c57ace909d2141ded4/preprints-83992-Screenshot_4.jpg)
The New Era of Therapeutic Strategies for the Treatment of Retinitis Pigmentosa: From Pathomolecular Mechanisms to the Development of Cell-Based Therapies[v1] | Preprints.org
Hirocon Singapore - Retinitis Pigmentosa causes gradual impairment of the night vision usually from childhood, inherited from parent. There is currently no cure for this condition, but there are measures to slow
![Molecular genetics and emerging therapies for retinitis pigmentosa: Basic research and clinical perspectives - ScienceDirect Molecular genetics and emerging therapies for retinitis pigmentosa: Basic research and clinical perspectives - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1350946217300526-fx1.jpg)
Molecular genetics and emerging therapies for retinitis pigmentosa: Basic research and clinical perspectives - ScienceDirect
![Successful arrest of photoreceptor and vision loss expands the therapeutic window of retinal gene therapy to later stages of disease | PNAS Successful arrest of photoreceptor and vision loss expands the therapeutic window of retinal gene therapy to later stages of disease | PNAS](https://www.pnas.org/cms/10.1073/pnas.1509914112/asset/f4d5f208-2249-4eda-9ceb-dc4c695faaf1/assets/graphic/pnas.1509914112fig01.jpeg)